iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments

Neil Gallagher M.D., Ph.D., former AbbVie Chief Medical Officer and President of R&D at Syndax, brings considerable experience in oncology drug developmentAnthony Mancini, currently Global Chief Commercial Officer at Revolution Medicines, led several successful oncology product launches at Genmab and BMSView original content:https://www.prnewswire.co.uk/news-releases/ionctura-strengthens-medical-and-commercialization-expertise-with-two-non-executive-board-appointments-302512288.html

en | boerse | 67948314 |